Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...

FOX 5 Journalist Judayah Murray shares the inspiring story of Joanne Cure, a woman who developed advanced lung cancer despite being a non-smoker. FOX 5’s Kevyn Stewart spoke with Joanne about her ...

The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...

The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...

Approximately 20% of new lung cancer diagnoses occur in nonsmokers in the U.S., according to The Ohio State University ...

With 18.7% of eligible adults reporting being up to date on lung cancer screening in a national survey, this was estimated to ...

New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 ...

The study of the respiratory system microbiome is a burgeoning field that has recently garnered significant attention.

A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.

A new study published in the journal of BMC Psychiatry showed that adults diagnosed with depression before the age of 16 had ...

Nearly 8% of Ohioans live with chronic obstructive pulmonary disease (COPD), a long-term, progressive lung disease that causes difficulty breathing. In fact, Ohio is among the states in the country ...

Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free survival in CSCC in the adjuvant setting, reducing the risk of ...